Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nicholas J. Goel, Cylaina E. Bird, William H. Hicks & Kalil G. Abdullah. (2021) Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessment. Journal of Medical Economics 24:1, pages 1018-1024.
Read now
Read now
Shan Jiang, Kala Hill, Dipen Patel, A. Reginald Waldeck, Marc Botteman, Abdalla Aly & Andrew D. Norden. (2017) Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients. Journal of Medical Economics 20:12, pages 1237-1243.
Read now
Read now
Carin A Uyl-de Groot, Saskia de Groot & Adri Steenhoek. (2010) The economics of improved cancer survival rates: better outcomes, higher costs. Expert Review of Pharmacoeconomics & Outcomes Research 10:3, pages 283-292.
Read now
Read now
Articles from other publishers (13)
Nidhi Gupta, Shankar Prinja, Vijay Patil & Pankaj Bahuguna. (2021) Cost-Effectiveness of Temozolamide for Treatment of Glioblastoma Multiforme in India. JCO Global Oncology:7, pages 108-117.
Crossref
Crossref
Gideon Adegboyega, Ahmad Ozair, Ulrick Sidney Kanmounye, Soham Bandyopadhyay & Babar Vaqas. (2021) Letter: Is the Stupp Protocol an Expensive and Unsustainable Standard of Care for Glioblastoma in Low- and Middle-Income Country Settings? A Call to Action!. Neurosurgery 89:4, pages E249-E251.
Crossref
Crossref
Kevin Paul Ferraris, Maria Eufemia C. Yap, Maria Cristina G. Bautista, Dewa Putu Wisnu Wardhana, Sri Maliawan, I Made Ady Wirawan, Rohadi Muhammad Rosyidi, Kenny Seng & Joseph Erroll Navarro. (2021) Financial Risk Protection for Neurosurgical Care in Indonesia and the Philippines: A Primer on Health Financing for the Global Neurosurgeon. Frontiers in Surgery 8.
Crossref
Crossref
Thara Tunthanathip, Surasak Sangkhathat, Pimwara Tanvejsilp & Kanet Kanjanapradit. (2020) The clinical characteristics and prognostic factors of multiple lesions in glioblastomas. Clinical Neurology and Neurosurgery 195, pages 105891.
Crossref
Crossref
Thara Tunthanathip & Surasak Sangkhathat. (2020) Temozolomide for patients with wild-type isocitrate dehydrogenase (IDH) 1 glioblastoma using propensity score matching. Clinical Neurology and Neurosurgery 191, pages 105712.
Crossref
Crossref
Vicki Marie Butenschoen, Anna Kelm, Bernhard Meyer & Sandro M. Krieg. (2019) Quality-adjusted life years in glioma patients: a systematic review on currently available data and the lack of evidence-based utilities. Journal of Neuro-Oncology 144:1, pages 1-9.
Crossref
Crossref
D. Ryan Ormond, Alexandros Bouras, Michael Moore, Matthew Gary, Paula Province Warren, Roshan Prabhu, Kathleen M. Egan, Srikant Rangaraju, Christina Appin, Constantinos Hadjipanayis, Burt Nabors, Alfredo Voloschin & Jeffrey J. Olson. 2018. The American Cancer Society's Oncology in Practice. The American Cancer Society's Oncology in Practice
571
607
.
YouRong Sophie Su & Kalil G. Abdullah. 2016. Glioblastoma. Glioblastoma
271
278
.
Jeffrey J. RaizerKaren A. FitznerDaniel I. JacobsCharles L. BennettDustin B. LieblingThanh Ha LuuSteven M. TrifilioSean A. GrimmMatthew J. FisherMeraaj S. HaleemPaul S. RayJudith M. McKoyRebecca DeBoerKatrina-Marie E. TulasMohammed DeebJune M. McKoy. (2015) Economics of Malignant Gliomas: A Critical Review. Journal of Oncology Practice 11:1, pages e59-e65.
Crossref
Crossref
G. Diebold, F. Ducray, A.-M. Henaine, D. Frappaz, J. Guyotat, S. Cartalat-Carel, V. Breant, A. Fouquet, G. Aulagner, J. Honnorat & X. Armoiry. (2014) Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital. Journal of Clinical Pharmacy and Therapeutics 39:6, pages 642-648.
Crossref
Crossref
Alexander Heinzel, Stephanie Stock, Karl-Josef Langen & Dirk Müller. (2012) Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas. European Journal of Nuclear Medicine and Molecular Imaging 39:7, pages 1089-1096.
Crossref
Crossref
Bin Wu, Yifeng Miao, Yongrui Bai, Min Ye, Yuejuan Xu, Huafeng Chen, Jinfang Shen & Yongming Qiu. (2012) Subgroup Economic Analysis for Glioblastoma in a Health Resource-Limited Setting. PLoS ONE 7:4, pages e34588.
Crossref
Crossref
Alexander Heinzel, Stephanie Stock, Karl-Josef Langen & Dirk Müller. (2012) Cost-Effectiveness Analysis of Amino Acid PET–Guided Surgery for Supratentorial High-Grade Gliomas. Journal of Nuclear Medicine 53:4, pages 552-558.
Crossref
Crossref